Work

Updated Results from Phase 1 Study of Targeted Radiotherapy with Lintuzumab-Ac225 in Combination with Venetoclax in Relapsed/Refractory AML

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-178802

Authors: Gail J. Roboz, Laura E. Finn, Johnnie J. Orozco, Mohamed Hegazi, Avinash Desai, Mary Chen, Gary J. Schiller

Institutions: NewYork–Presbyterian Hospital, Weill Cornell Medicine, Ochsner Medical Center, Fred Hutch Cancer Center, University of Louisville, Actinium Pharmaceuticals (United States), University of California, Los Angeles

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389247749

Cites:

Cited by: 3

Related to: 10